KONRAD SHERINIAN

Profile

Konrad Sherinian represents clients in the Intellectual Property and Commercial Litigation matters. He concentrates his practice in three areas:

First, Konrad works with inventors and technology companies to obtain patent protection for their inventions. Since being admitted to practice before the Patent & Trademark Office in 2004, Konrad has written more than 200 patent applications, with issued patents in technology areas ranging from software to radio-controlled aircraft. Certain of those patents were subsequently asserted and tested in federal court. 

Second, Konrad represents clients in administrative proceedings before the Patent & Trademark Office. This includes proceedings before the Patent Trials and Appeal Board, as well as the Trademark Trials and Appeal Board. Konrad has served as lead counsel in five proceedings before the Patent Trial and Appeal Board and the Trademark Trial and Appeal Board: two inter partes reviews, one PTAB appeal, and two TTAB matters in which he represented the defendant. All five were resolved by a favorable decision or by settlement.

Third, Konrad represents clients in commercial litigation matters with a primary focus on intellectual property and technology cases in both Illinois and District Courts throughout the country. He is admitted to practice before the Northern District of Illinois, the Central District of Illinois, the Eastern District of Wisconsin, and the Western District of Wisconsin. He has also appeared pro hac vice in other courts throughout the country.

Prior to becoming an attorney, Mr. Sherinian worked for many years as an engineer, including roles in electrical design, digital design, and software. He holds an issued patent on video game technology. 

Konrad is a prior co-chair of the ABA’s Inequitable Conduct Subcommittee, and has authored multiple articles and made numerous presentations to various groups on intellectual property and litigation. He resides in Naperville with his children.

Prior results do not guarantee future outcomes.